Treatment of neuropathic pain is a major clinical challenge that has been met with minimal success. After peripheral nerve injury, a decrease in the expression of the K-Cl cotransporter KCC2, a major neuronal Cl À extruder, leads to pathologic alterations in GABA A and glycine receptor function in the spinal cord.
a b s t r a c t
Treatment of neuropathic pain is a major clinical challenge that has been met with minimal success. After peripheral nerve injury, a decrease in the expression of the K-Cl cotransporter KCC2, a major neuronal Cl À extruder, leads to pathologic alterations in GABA A and glycine receptor function in the spinal cord.
The down-regulation of KCC2 is expected to cause a reduction in Cl À extrusion capacity in dorsal horn neurons, which, together with the depolarizing efflux of HCO À 3 anions via GABA A channels, would result in a decrease in the efficacy of GABA A -mediated inhibition. Carbonic anhydrases (CA) facilitate intracellular HCO À 3 generation and hence, we hypothesized that inhibition of CAs would enhance the efficacy of GABAergic inhibition in the context of neuropathic pain. Despite the decrease in KCC2 expression, spinal administration of benzodiazepines has been shown to be anti-allodynic in neuropathic conditions. Thus, we also hypothesized that spinal inhibition of CAs might enhance the anti-allodynic effects of spinally administered benzodiazepines. Here, we show that inhibition of spinal CA activity with acetazolamide (ACT) reduces neuropathic allodynia. Moreover, we demonstrate that spinal co-administration of ACT and midazolam (MZL) act synergistically to reduce neuropathic allodynia after peripheral nerve injury. These findings indicate that the combined use of CA inhibitors and benzodiazepines may be effective in the clinical management of neuropathic pain in humans.
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Introduction
Neuropathic pain is a major clinical problem that, despite increasing basic science understanding of the disorder, is still poorly managed by available therapeutics. Recent preclinical work in neuropathic pain models suggests that peripheral nerve injury (PNI) results in a pathology of the spinal GABAergic system. This may include decreases in spinal dorsal horn GABAergic interneurons [24] , decreases in GABA release [24] (but see [27, 34] ) or alterations in GABA A and glycine receptor reversal potentials [9, 10, 28] attributed to a decrease in K + -Cl À cotransporter type 2 (KCC2) expression in spinal dorsal horn neurons [10] . A possible mechanism to reverse these effects is through treatment with benzodiazepines [20, 21, 41] which augment spinal GABAergic neurotransmission postsynaptically. This notion is supported by the efficacy of spinally applied benzodiazepines for chronic pain conditions in humans (for review see [12] ); and their efficacy in preclinical pain models [20, 21] .
While spinally administered benzodiazepines are clearly antiallodynic in neuropathic conditions [20] it is also true that reduced KCC2 expression after peripheral nerve injury causes a decrease in the efficacy of inhibition mediated by GABA A and glycine receptors in a subset of dorsal horn neurons [10, 28] . This reduction of KCC2 expression would reduce the Cl À extrusion capacity of dorsal horn neurons leading to a reduction of Cl À mediated hyperpolarization through GABA A and glycine channels. Under physiological conditions, GABA A receptor channels mediate substantial currents carried not only by Cl À but also by HCO À 3 [15, 16] as do glycine receptors [4] . Hence, a reduced Cl À extrusion capacity will favor the depolarizing channel-mediated efflux of HCO À 3 , especially in neurons equipped with cytoplasmic carbonic anhydrase (CA). Because this enzyme is able to quickly replenish intracellular HCO À 3 during the channel-mediated net efflux, the HCO À 3 -dependent depolarization can become large enough to result in GABAergic or glycinergic excitation during ongoing neuronal network activity, as previously demonstrated in the adult rat hippocampus [33, 38] . Notably, synchronous network activity in the dorsal horn of the spinal cord is enhanced after PNI [35] . Therefore, inhibition of CA after PNI may be expected to reduce HCO 
